Patents by Inventor Michael A. Frohman

Michael A. Frohman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel phospholipase D polypeptide and DNA sequences
    Publication number: 20030124108
    Abstract: Provided are novel phospholipase D DNA and amino acid sequences. The sequences are useful in methods and compositions for identifying phospholipase D mediator molecules which are in turn useful in therapeutic pharmacuetical compositions for treating rheumatoid arthritis, psoriasis, ulcerative colitis, in wound healing and for treating other diseases or conditions characterized by exhibition of an inflammatory response or in the treatment of cancer and other diseases characterized by pathogenic mitogenicity.
    Type: Application
    Filed: April 30, 2002
    Publication date: July 3, 2003
    Inventors: Michael A. Frohman, Andrew J. Morris, Joanne Engebrecht
  • Phospholipase D polypeptide and DNA sequences
    Patent number: 6379665
    Abstract: Provided are novel phospholipase D DNA and amino acid sequences. The sequences are useful in methods and compositions for identifying phospholipase D mediator molecules which are in turn useful in therapeutic pharmaceutical compositions for treating rheumatoid arthritis, psoriasis, ulcerative colitis, in wound healing and for treating other diseases or conditions characterized by exhibition of an inflammatory response or in the treatment of cancer and other diseases characterized by pathogenic mitogenicity.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: April 30, 2002
    Assignee: Onyx Pharmaceuticals, Inc.
    Inventors: Michael A. Frohman, Andrew J. Morris, Joanne Engebrecht
  • Phospholipase D polypeptide and DNA sequences
    Patent number: 6043073
    Abstract: Provided are novel phospholipase D DNA and amino acid sequences. The sequences are useful in methods and compositions for identifying phospholipase D mediator molecules which are in turn useful in therapeutic pharmacuetical compositions for treating rheumatoid arthritis, psoriasis, ulcerative colitis, in wound healing and for treating other diseases or conditions characterized by exhibition of an inflammatory response or in the treatment of cancer and other diseases characterized by pathogenic mitogenicity.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: March 28, 2000
    Assignee: The Research Foundation of the State University of New York
    Inventors: Michael A. Frohman, Andrew J. Morris, Joanne Engebrecht